When the novel coronavirus first reached Europe, the married scientists Uur ahin and zlem Treci were working in the small town of Mainz, Germany, at the helm of a biotech company that relatively few people had heard of. The couple founded BioNTech in 2008 to develop individualized vaccines for cancer patients. But the company specialized in a type of genetic material, messenger RNA, that had also shown promise for other diseases including viral infections.
So when ahin read an article about Covid-19 in January 2020, he and Treci both recognized that their companys mRNA technology might have something powerful to contribute. Treci, BioNTechs chief medical officer, led a team that rapidly whittled down 20 vaccine candidates to just one: BNT162b2, which could be described as the shot that changed the world. BioNTech partnered with the pharmaceutical giant Pfizer, and in July 2020, the US placed a $1.95 billion order. A few months later, the German government gave BioNTech a $445 million grant to speed up research and production.
The Pfizer/BioNTech vaccine was the worlds first approved Covid-19 vaccine, and it has helped protect more than a billion people from the coronavirus. The mRNA inside the shot instructs human cells to produce a protein that Treci compares to a wanted poster. The protein warns the immune system to watch out for the coronavirus.
Meanwhile, ahin and Treci became famous almost overnight. We are incredibly proud to have such researchers in our country, Angela Merkel, then-chancellor of Germany and a chemist by training, said in December 2020. In March, they were awarded one of the nations highest honors, the Knight Commanders Cross of the Federal Order of Merit. Though ahin and Treci are now billionaires, they are known for living modestly, commuting to work by bicycle and working long hours in the lab.
But the companys ascent has also come with new scrutiny. When I sat down with Treci at the Falling Walls Science Summit in early November, BioNTech, its partner Pfizer, and its competitor Moderna had been drawing fierce criticism for huge, persistent gaps in access to Covid-19 vaccines. The vast majority of Pfizer/BioNTech vaccine doses have gone to a small minority of people roughly 16 percent of the worlds population who live in high-income countries.
It is obscene that just a few companies are making millions of dollars in profit every single hour, while just 2.5 percent of people in low-income countries have been fully vaccinated against coronavirus, said Maaza Seyoum of the Peoples Vaccine Alliance, which has joined the African Union, India, and the US government in calling on vaccine producers to waive their patents so more countries and companies can produce them. Pfizer, BioNTech, and Moderna have used their monopolies to prioritize the most profitable contracts with the richest governments, leaving low-income countries out in the cold.
I asked Treci about what BioNTech can do about vaccine inequity, and the company also provided a statement to Vox. As a Covid-19 vaccine manufacturer we see it as our responsibility to support the worldwide supply of the Pfizer/BioNTech vaccine by continuously increasing our manufacturing capacities, a spokesperson said, adding that the companies are in the process of doubling their production capacity and plan to make more than 3 billion doses in 2022. We are fully committed to supplying our vaccine to people around the world in all countries and across all income levels.
Treci also discussed the scientific process, the state of the pandemic, and what the past two years have been like. Our conversation has been edited and condensed.
Can you tell me about the first moment you realized that you and your team could play a big role in fighting Covid-19?
It was the last weekend in January 2020, and my husband who is with me the founder of the company read about the virus. The pattern that was described made it very clear that we were already in the midst of a pandemic. It was very clear that a vaccine would be needed as fast as possible. And our technology, which we had optimized for moving fast from a known genetic sequence to vaccine design to manufacturing it was very clear that it would contribute in this situation. This was the epiphany.
Your team had been working on mRNA vaccines for many years, and your company had recently sold shares to the public and received some major investments. BioNTech was in the right place at the right time but, of course, this wasnt by accident. What have you learned about preparing for the next problem that humans havent encountered yet?
Even though it might have seemed that way, this was not something which was developed overnight, as an immediate reaction. We started in the mid-1990s to experiment with mRNA. In 2012, we treated our first patient. These were long years of preparation.
The next threats are already there but a sense of urgency is not there yet. It is very important, without already seeing the clear threat, to have a vision which can serve as a North Star. And with this perseverance and grit, to work toward actualizing the potential of the technology and trusting in the science to solve it.
The second most important thing is to understand that we are a global community. We are scientists. It wasnt too clear to us what nonscientific challenges geopolitical ones, global ethical ones, societal ones had to be overcome to make all this feasible. Understanding that those are major hurdles, and starting to fix them early on, is important.
Your insight is that we have to treat future problems with the urgency of the present day. We cant wait for them to emerge, but we should move forward as though they are already here.
Yes. And this is an anthropological thing. Our ancestors have been prepared by evolution to feel alerted and react to anything that is immediately there. We still have this in us. Even though we can visualize what will happen take the climate, for example we push it aside.
What do you wish you had done differently?
There is actually nothing I wish I had done differently. It is difficult to reverse-engineer what would have been different with a different action. So the way we did it was the right one.
What do you think the near future holds for the Covid-19 pandemic? What are you concerned about, and what gives you hope?
What I think is important is that we continue to vaccinate. Infection rates and disease rates are rising again. These are not primarily in the vaccinated but rather the unvaccinated. So we need to reach them.
Equality of distribution is obviously a topic. We are trying to do our share by even further increasing our production and going to all those underserved regions for production facilities.
We have to continue to be alert and test each and every emerging variant to understand when the signal is there to adapt the vaccine to a potential escape variant and not act prematurely or preemptively.
We have to also see what has been achieved. More than a billion humans have been vaccinated [with the Pfizer/BioNTech vaccine]. Several vaccines are available. So its also important to see the positive side of this.
How do you stay optimistic when cases rise? For example, right now, in Europe and here in Germany, cases are near record highs after the rollout of this very effective vaccine.
The same way that scientists always do: to focus on solutions which can help. For the current situation, this includes continuing with production and delivery, informing the public about the need for a third booster dose, and providing the data very transparently to the authorities.
You mentioned inequity across the world in distribution. In wealthy countries, around 70 percent of people are vaccinated, but in low-income countries like Haiti or Tanzania, the rate is often under 10 percent. What else can governments and vaccine producers do to close that really large gap?
I think there is not much we can add on top other than what we are already doing as developers and also companies and institutions. Covax, for example, has to facilitate what is not so easy to deliver to those countries.
I think also it is important to ensure the high quality of vaccines going to those countries, and therefore I dont like this discussion about patent waivers. In those countries, there is some vaccine hesitancy. People want to be sure that the vaccine they get has the same high quality as we have here in the Western world, where regulatory authorities ensure that, and the manufacturers are qualified to produce the vaccine. Its important that we keep vaccine quality on the same standard and continue to educate and inform the public there.
[After speaking with Treci, I asked advocates whether patent waivers could lead to the production of lower-quality vaccines. Anna Marriott, health policy manager at Oxfam a member of the Peoples Vaccine Alliance said in a statement that its nonsense to claim that the experience and expertise to develop and manufacture lifesaving medicines and vaccines does not exist in developing countries. This is just a false excuse that pharmaceutical companies are hiding behind to protect their astronomical profits.]
Are you troubled by the low numbers of doses that are delivered to low-income countries?
Actually, I dont think that low numbers in terms of input is a real problem. For example, 40 percent of what we have delivered and this will continue have gone to low- and middle-income countries. [Vox asked BioNTech for data supporting that figure, but the company didnt provide it and we were unable to independently verify the claim.]
In the beginning, getting the framework right, from a geopolitical and logistical and distribution perspective, was a hurdle and we have overcome that as a global society. Not fully, but important steps have been made, and this has to continue.
What advice would you give to the generation of scientists that may have to respond to the next pandemic?
One needs to be courageous to do things that are risky. On the other side, its very important to have humility. Threats of this unprecedented scale and of a global dimension you can only overcome them with science if you get support from all involved. That needs an interaction which is based on humility and also on trust.
In the past year and a half, you [and your husband] have been extremely busy. Have you found any time for yourself?
We are not really those who distinguish between life and work. We are blessed that what we do is what we love to do. So its not really about time for something special. What we do is already fulfilling.
Here is the original post:
BioNTechs zlem Treci on the Covid-19 pandemic and the vaccine gap - Vox
- COVID-19 vaccine clinic for kids age 5-11 this Saturday at Riverbend City and Borough of Juneau - City and Borough of Juneau - December 3rd, 2021
- AdventHealth suspends COVID-19 vaccine requirements for employees - West Orange Times & Windermere Observer - December 3rd, 2021
- Get vaccinated before the holidays at Oshkosh's popup COVID-19 vaccine clinic - Fox11online.com - December 3rd, 2021
- What will tomorrow's Covid-19 vaccines be like? - BBC News - December 3rd, 2021
- Europe Sees Boost in Uptake of Covid-19 Shots but Vaccine Mandates Are Still on the Table - The Wall Street Journal - December 3rd, 2021
- COVID-19 vaccines are not gene therapy and a Forbes article doesn't say they are - PolitiFact - December 3rd, 2021
- COVID-19 Update: CTTP hours during finals and break, COVID-19 Vaccines and Flu Shots - Carolina Together : Carolina Together - Carolina Together - December 3rd, 2021
- Celebrity Kids Getting the COVID-19 Vaccine: Photos - Us Weekly - December 3rd, 2021
- Czechs to mandate COVID-19 vaccination for over 60s -news website - Reuters - December 3rd, 2021
- DeKalb County is offering $100 to everyone who gets COVID-19 vaccine there - 11Alive.com WXIA - December 3rd, 2021
- Top 10 counties with the highest COVID-19 vaccination rate in Virginia - 8News - December 3rd, 2021
- With Queensland about to open its border, COVID-19 vaccine hesitancy is waning but protests are getting bigger - ABC News - December 3rd, 2021
- Factbox: What COVID-19 vaccine and drug makers have to say about Omicron - Reuters - December 3rd, 2021
- Mongolian Government To Build On COVID-19 Vaccine And Booster Success - PRNewswire - December 3rd, 2021
- How quickly does protection wane after the Pfizer COVID-19 vaccine? - Medical News Today - December 2nd, 2021
- Greece will mandate the COVID-19 vaccine for anyone over 60, or make them pay fines - NPR - December 2nd, 2021
- First COVID-19 vaccine administered in Washington is given to 13 healthcare workers on December 15, 2020. - HistoryLink.org - December 2nd, 2021
- There's no proof COVID-19 vaccines are causing healthy athletes to collapse - PolitiFact - December 2nd, 2021
- First U.S. omicron patient was fully vaccinated and has mild Covid symptoms, officials say - CNBC - December 2nd, 2021
- New data on the link between COVID-19 vaccines and myopericarditis - Cardiovascular Business - December 2nd, 2021
- Italy approves COVID-19 vaccination for 5-11 year olds - Reuters - December 2nd, 2021
- Contributor: While Many Americans Refuse COVID-19 Vaccination, People Affected by HIV Have Been Waiting for 40 Years - AJMC.com Managed Markets... - December 2nd, 2021
- Health officials recommend getting COVID-19 vaccine and booster as they learn more about Omicron variant - whnt.com - December 2nd, 2021
- Maryland-Based Vaccine Manufacturer Developing COVID-19 Vaccine That Targets Omicron Variant - CBS Baltimore - December 2nd, 2021
- Omicron brings COVID-19 vaccine inequity home to roost - Boston.com - December 2nd, 2021
- European Union mulling mandatory COVID-19 vaccinations - Fox News - December 2nd, 2021
- Hundreds of NYC correction officers to be suspended for failing to meet COVID-19 vaccination deadline - Fox News - December 2nd, 2021
- KDHE Vaccine KS | Official Website - November 29th, 2021
- COVID Vaccine Eat This Not That - November 29th, 2021
- Why Moderna refuses to share the rights for a COVID-19 vaccine developed with taxpayer funding - Milwaukee Independent - November 29th, 2021
- Covid-19 Vaccine Makers Assess Omicron Response - The Wall Street Journal - November 29th, 2021
- Moderna says its COVID-19 vaccine protective, safe in ... - November 29th, 2021
- Covid-19 Vaccine and Omicron Variant: Live Updates - The New York Times - November 29th, 2021
- Social media on the acceptance of the COVID-19 vaccine | PPA - Dove Medical Press - November 29th, 2021
- Are covid-19 vaccines effective against the omicron variant? - Quartz - November 29th, 2021
- Vaccine booster time frame to be reviewed as COVID-19 Omicron variant appears in Australia - ABC News - November 29th, 2021
- Former WH advisor: Trump would already have new vaccines for Omicron - Business Insider - November 29th, 2021
- Egypt is one step away from its first national COVID-19 vaccine - Egypt Independent - November 29th, 2021
- Covid-19 Vaccines or Infections: Which Carries the Stronger Immunity? - The Wall Street Journal - November 27th, 2021
- COVID19 Vaccine Tracker - November 27th, 2021
- COVID hit this family twice, but vaccines blunted reinfections : Shots - Health News - NPR - November 27th, 2021
- NC Marines involved in litigation over COVID-19 vaccine mandate - Jacksonville Daily News - November 27th, 2021
- Union County Offers Additional Sites for Free COVID-19 Vaccines and Booster Shots this Week County of Union, New Jersey - UCNJ.org - November 27th, 2021
- Some LGBTQ+ people worry that the COVID-19 vaccine will affect HIV medication. It won't. - WFAE - November 27th, 2021
- Johnson & Johnson Covid-19 Vaccine Recipients Often Shift to Other Boosters - The Wall Street Journal - November 27th, 2021
- COVID-19 vaccine: Antibodies more than halved after 6 months - Medical News Today - November 27th, 2021
- COVID-19 Vaccines Tested in Low-Income Countries, But Distributed in Wealthy Nations - Contagionlive.com - November 27th, 2021
- WHO labels new Covid strain, named omicron, a 'variant of concern,' citing possible increased reinfection risk - CNBC - November 27th, 2021
- COVID-19: Top news stories about the coronavirus pandemic on 26 November | World Economic Forum - World Economic Forum - November 27th, 2021
- How one discredited 1998 study paved the way for today's anti-vaxxers - Salon - November 27th, 2021
- Letter to the editor: Shame on Vail Resorts for COVID-19 vaccine mandate - Summit Daily News - November 27th, 2021
- Omicron concerns should spur millions of unvaccinated Americans to get their Covid shots, experts say - CNN - November 27th, 2021
- Thanksgiving is possible this year because of Covid-19 vaccines - MSNBC - November 25th, 2021
- Could a COVID-19 vaccine patch be better than injections? - Aljazeera.com - November 25th, 2021
- Pediatric COVID-19 vaccine clinics happening next week, Nov. 29 Dec. 4 City and Borough of Juneau - City and Borough of Juneau - November 25th, 2021
- Pediatric COVID-19 vaccine supply catches up with demand in Indianapolis metro area - WISHTV.com - November 25th, 2021
- CDC authorizes COVID-19 vaccine booster doses for all adults ages 18 and up | Arizona Emergency information Network - az.gov - November 25th, 2021
- Poll: Majority of Thanksgiving hosts not requiring COVID-19 vaccine, masks - The Hill - November 25th, 2021
- The effectiveness of Covid-19 vaccines illustrated by two graphs - EL PAS in English - November 25th, 2021
- Gov. Hochul announces COVID-19 vaccine incentive aimed at outdoor enthusiasts - WKBW-TV - November 25th, 2021
- Yes, you can get the COVID-19 vaccine if you have mild cold symptoms: doctor - KRON4 - November 25th, 2021
- This Is How Many COVID-19 Vaccines Washington Has Received So Far - Patch.com - November 25th, 2021
- Governor Hochul Announces Direct Messaging Efforts to Increase COVID-19 Vaccination and Booster Rates Among New Yorkers - NY.gov - November 25th, 2021
- COVID-19 Vaccine - Southern Nevada Health District - November 23rd, 2021
- More than 90% of federal workers have had a shot by today's COVID-19 vaccine deadline - NPR - November 23rd, 2021
- Our COVID-19 Response Efforts | Johnson & Johnson - November 23rd, 2021
- COVID-19 Vaccination Scheduling Options - November 23rd, 2021
- EU says decision on J&J COVID-19 vaccine booster dose 'within weeks' - Reuters - November 23rd, 2021
- COVID-19 vaccination status and time until return to work among healthcare workers - News-Medical.net - November 23rd, 2021
- MCPS softens COVID-19 vaccination mandate to allow for weekly testing instead - BethesdaMagazine.com - November 23rd, 2021
- Plenty of COVID-19 vaccine appointments available in Triangle ahead of the holiday - CBS17.com - November 23rd, 2021
- Many men dont take good care of themselves. COVID-19 vaccine rates are the latest in a problem as old as medicine. - The Philadelphia Inquirer - November 23rd, 2021
- Chicago Hits Goal As 77% Of Residents 12 And Older Have Gotten 1 Shot Of COVID-19 Vaccine - Block Club Chicago - November 23rd, 2021
- New UMass Amherst/WCVB poll on children being vaccinated against COVID-19 - WCVB Boston - November 23rd, 2021
- Maui Pediatrician Discusses Safety and Efficacy of the COVID-19 Vaccine in Kids - Maui Now - November 21st, 2021
- 20 counties with the highest COVID-19 vaccination rate in California - KTLA - November 21st, 2021
- Why Moderna wont share rights to the COVID-19 vaccine with the government that paid for its development - KRQE News 13 - November 21st, 2021
- 6-year-old son of Boston Mayor Michelle Wu receives first dose of COVID-19 vaccine - WCVB Boston - November 21st, 2021
- More than half of Athens County has begun the COVID-19 vaccination process as of Nov. 20 - WOUB - November 21st, 2021
- Unvaccinated-Only Lockdowns Come to Europe - The Atlantic - November 21st, 2021